- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Phone App For Melanoma Screening to be Tested at MD Anderson
DermoScan, created by an engineering faculty at the University of Houston, can help screen for melanoma. It has already been used to diagnose a dermal bacterial disease in Africa, in a NIH-sponsored study.
The idea sounds simple: Take a photo of a suspicious mole or lesion with your phone, run it through an embedded software program and find out within a few seconds if it is likely to be cancerous.
But it could make quick and inexpensive screening a reality for millions of people who lack access to medical specialists. A University of Houston professor created the
, called DermoScan, which is now being evaluated for further testing at the University of Texas MD Anderson Cancer Center. George Zouridakis, professor of
, has worked on the project since 2005, moving it to an application for a
after the iPhone became ubiquitous. The goal is to provide quick screening in rural areas or in the developing world, where specialty medical care generally isn't available, he said.
Early testing found the device to be accurate about 85 percent of the time, Zouridakis said, similar to the accuracy rate for dermatologists and more accurate than primary care physicians. Patients would be referred for follow-up if the lesion were suspected to be cancerous.
Read the original report here: http://bit.ly/1mCvYAx
Source: MedicalXpress
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
